Q4 2025 Holdings
Filed 2026-02-17 | 20 holdings | $96.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Replimune Group Inc(REPL)Call | COM | 76029N106 | $11.7M | 1,200,000 | 12.5% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $9.4M | 70,000 | 10.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $7.8M | 168,029 | 8.3% |
| Compass Pathways PLC(CMPS)Call | SPONSORED ADS | 20451W101 | $7.6M | 1,100,000 | 8.1% |
| Atai Beckley NV | SHS | N0731H103 | $7.0M | 1,713,105 | 7.5% |
| Inventiva SA(IVA) | ADS | 46124U107 | $7.0M | 1,500,000 | 7.5% |
| Minerva Neurosciences Inc(NERV) | COM NEW | 603380205 | $6.7M | 1,655,500 | 7.1% |
| Edgewise Therapeutics Inc(EWTX)Put | COM | 28036F105 | $6.2M | 250,000 | 6.6% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $5.9M | 19,882 | 6.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $4.8M | 195,000 | 5.2% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $3.0M | 397,895 | 3.2% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $2.9M | 1,785,000 | 3.1% |
| Taysha Gene Therapies Inc(TSHA)Call | COM SHS | 877619106 | $2.8M | 500,000 | 2.9% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $2.5M | 457,132 | 2.7% |
| Uniqure NV(QURE)Call | SHS | N90064101 | $2.4M | 100,000 | 2.6% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $2.3M | 413,625 | 2.5% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $2.0M | 817,939 | 2.1% |
| Promis Neurosciences Inc(PMN) | COM SHS | 74346M505 | $1.7M | 249,339 | 1.8% |